Global Custom Market Research Reports Provider Company

phone

BioArctic AB (BIOA B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 27 Aug 2018
  • Number of Pages: 30
  • Category: Company Profile
  • Country: Sweden
Summary

BioArctic AB (BioArctic), formerly BioArctic Neuroscience AB, is a biopharma company that develops new immunotherapeutic treatments for patients with central nervous system disorders. The company develops drugs for neurological disorders such as Parkinsons disease, Alzheimers disease and spinal cord injury. It develops alzeimer antibodies. BioArctics reagents include AB antibody AbetaN, Alzheimer biomarker and parkinson biomarker. The companys antibodies have the capability to reduce soluble, toxic aggregated proteins in the brain. It develops new treatments for Parkinsons disease and Dementia with Lewy bodies. The company collaborates with research groups at universities and hospitals. BioArctic is headquartered in Stockholm, Sweden.

BioArctic AB (BIOA B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioArctic AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioArctic AB, Medical Devices Deals, 2012 to YTD 2018 9
BioArctic AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioArctic AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioArctic Enters into Research Agreement with Uppsala University 11
AbbVie Enters into Agreement with BioArctic 12
Licensing Agreements 13
BioArctic Receives Rights from Eisai 13
Equity Offering 14
BioArctic Raises USD99 Million in IPO of B-Shares 14
Acquisition 15
Karolinska Development Divests its Remaining Stake in BioArctic for USD1.4 Million 15
BioArctic AB - Key Competitors 16
BioArctic AB - Key Employees 17
BioArctic AB - Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Financial Announcements 19
Apr 26, 2018: BioArctic: Interim Report January March 2018 19
Feb 20, 2018: BioArctic: Full Year Report January December 2017 21
Nov 08, 2017: BioArctic: Interim Report January September 2017 22
Corporate Communications 24
Jun 27, 2018: BioArctic announces changes in the Management Team effective September 1, 2018 24
Oct 12, 2017: First day of trading in Karolinska Developments portfolio company BioArctics shares on Nasdaq Stockholm 25
Sep 13, 2017: Karolinska Developments Portfolio Company BioArctic Intends to list on Nasdaq Stockholm 26
Product News 27
04/25/2018: Inclusion completed of patients with complete spinal cord injury in the first panel of BioArctics ongoing study 27
03/21/2018: BioArctic receives regulatory approval in Norway for a clinical study in patients with Complete Spinal Cord Injury 28
02/21/2018: BioArctic receives regulatory approval in Estonia for a clinical study in patients with Complete Spinal Cord Injury 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List Of Tables


BioArctic AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioArctic AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioArctic AB, Deals By Therapy Area, 2012 to YTD 2018 8
BioArctic AB, Medical Devices Deals, 2012 to YTD 2018 9
BioArctic AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioArctic Enters into Research Agreement with Uppsala University 11
AbbVie Enters into Agreement with BioArctic 12
BioArctic Receives Rights from Eisai 13
BioArctic Raises USD99 Million in IPO of B-Shares 14
Karolinska Development Divests its Remaining Stake in BioArctic for USD1.4 Million 15
BioArctic AB, Key Competitors 16
BioArctic AB, Key Employees 17

List Of Figures


BioArctic AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioArctic AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioArctic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioArctic AB, Medical Devices Deals, 2012 to YTD 2018 9

SELLAS Life Sciences Group Inc (SELLAS), formerly Galena Biopharma Inc, is a clinical-stage biopharmaceutical company that develops novel cancer immunotherapeutics for a broad range of cancer indications. Its lead product

View Report

Qinghai Gelatin Co Ltd (Qinghai Gelatin) is a manufacturer and distributor of gelatin products. The companys product portfolio includes gelatin series, hard capsule series, soft capsule series, casing series, pharmaceutical

View Report

Arrogene Inc (Arrogene) is a developer of cancer therapeutics and imaging products. The company develops nanomedicine products for the treatment of primary brain, lung, and triple negative breast cancer, and

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports